Investor Rosenwald Lindsay A Md
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Rosenwald Lindsay A Md . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Date Form Target Prev
Shares
Current
Shares
Change
(Percent)
Ownership
(Percent)
Change
(Percent)
2024-09-25 13D/A FBIO / Fortress Biotech, Inc. 2,813,905 5,224,779
2024-01-03 13D/A FBIO / Fortress Biotech, Inc. 2,597,440 2,813,905
2023-11-21 13D/A FBIO / Fortress Biotech, Inc. 2,597,440
2017-01-27 13D/A FBIO / Fortress Biotech, Inc. 6,826,012
2016-01-28 13D FBIO / Fortress Biotech, Inc. 6,271,970
2015-01-05 13D OACQ / Origo Acquisition Corporation 1,285,000
2014-02-13 13G/A FBIO / Fortress Biotech, Inc. 5,592,191
2013-02-14 13G/A FBIO / Fortress Biotech, Inc. 3,594,511
2012-04-02 13G ASMB / Assembly Biosciences, Inc. 1,271,084
2012-02-14 13G FBIO / Fortress Biotech, Inc. 3,381,178